Literature DB >> 1469084

Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.

S Caillat-Zucman1, H J Garchon, J Timsit, R Assan, C Boitard, I Djilali-Saiah, P Bougnères, J F Bach.   

Abstract

The association of insulin-dependent diabetes mellitus (IDDM) with certain HLA alleles is well documented in pediatric patients. Whether a similar association is found in adult-on-set IDDM is not clear, although the disease occurs after the age of 20 in 50% of cases. HLA class II DRB1, DQA1, and DQB1 alleles were studied in 402 type I diabetics and 405 healthy controls (all Caucasian) using oligonucleotide typing after gene amplification. Alleles DRB1*03, DRB1*04, DQB1*0201, DQB1*0302, DQA1*0301, and DQA1*0501 were indeed enriched in diabetics and the highest relative risk was observed in patients carrying both the DRB1*03-DQB1*0201 and the DRB1*0402 or DRB1*0405-DQB1*0302 haplotypes. However none of these alleles, or specific residues, could alone account for the susceptibility to IDDM. Furthermore, there were major differences in HLA class II gene profiles according to the age of onset. Patients with onset after 15 yr (n = 290) showed a significantly higher percentage of non-DR3/non-DR4 genotypes than those with childhood onset (n = 112) and a lower percentage of DR3/4 genotypes. These non-DR3/non-DR4 patients, although presenting clinically as IDDM type 1 patients, showed a lower frequency of islet cell antibodies at diagnosis and a significantly milder initial insulin deficiency. These subjects probably represent a particular subset of IDDM patients in whom frequency increases with age. The data confirm the genetic heterogeneity of IDDM and call for caution in extrapolating to adult patients the genetic concepts derived from childhood IDDM.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1469084      PMCID: PMC443375          DOI: 10.1172/JCI116110

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes.

Authors:  G Sterkers; D Zeliszewski; A M Chaussée; I Deschamps; M P Font; C Freidel; J Hors; H Betuel; J Dausset; J P Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

2.  HLA-DQ system and insulin-dependent diabetes mellitus in Japanese: does it contribute to the development of IDDM as it does in Caucasians?

Authors:  J M Aparicio; A Wakisaka; A Takada; N Matsuura; M Aizawa
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

3.  A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus.

Authors:  O Cohen-Haguenauer; E Robbins; C Massart; M Busson; I Deschamps; J Hors; J M Lalouel; J Dausset; D Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

4.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

5.  High-resolution analysis of the human HLA-DR polymorphism by hybridization with sequence-specific oligonucleotide probes.

Authors:  G Angelini; C de Preval; J Gorski; B Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  A simple and efficient non-organic procedure for the isolation of genomic DNA from blood.

Authors:  J Grimberg; S Nawoschik; L Belluscio; R McKee; A Turck; A Eisenberg
Journal:  Nucleic Acids Res       Date:  1989-10-25       Impact factor: 16.971

7.  Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility.

Authors:  G T Horn; T L Bugawan; C M Long; H A Erlich
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ.

Authors:  B Michelsen; A Lernmark
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

9.  Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus.

Authors:  R Assan; G Feutren; M Debray-Sachs; M C Quiniou-Debrie; C Laborie; G Thomas; L Chatenoud; J F Bach
Journal:  Lancet       Date:  1985-01-12       Impact factor: 79.321

10.  Use of pooled DNA samples to detect linkage disequilibrium of polymorphic restriction fragments and human disease: studies of the HLA class II loci.

Authors:  N Arnheim; C Strange; H Erlich
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

View more
  56 in total

1.  Selecting culprits in type 1 diabetes beta-cell killing.

Authors:  A Lernmark
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 2.  Genetic predisposition to IDDM.

Authors:  S Caillat-Zucman; J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 3.  Early induction of type 1 diabetes.

Authors:  M I Hawa; R D Leslie
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

4.  Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes--indication of an increased environmental pressure?

Authors:  R Hermann; M Knip; R Veijola; O Simell; A-P Laine; H K Akerblom; P-H Groop; C Forsblom; K Pettersson-Fernholm; J Ilonen
Journal:  Diabetologia       Date:  2003-03-18       Impact factor: 10.122

5.  T-cell response to proinsulin and insulin in type 1 and pretype 1 diabetes.

Authors:  D Dubois-LaForgue; J C Carel; P F Bougnères; J G Guillet; C Boitard
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

6.  The association between the HLA-G 14-bp insertion/deletion polymorphism and type 1 diabetes.

Authors:  H P V Silva; M A G Ururahy; K S C Souza; M B Loureiro; Y M C Oliveira; G H M Oliveira; A D Luchessi; K T C Carvalho; J C O C Freitas; E A Donadi; R D C Hirata; M G Almeida; R F Arrais; M H Hirata; A A Rezende
Journal:  Genes Immun       Date:  2015-10-22       Impact factor: 2.676

7.  Comment on: Gale EAM (2005) Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 48:2195-2199.

Authors:  A Clark; M Desai
Journal:  Diabetologia       Date:  2006-07-11       Impact factor: 10.122

8.  Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.

Authors:  K Decochez; I Truyen; B van der Auwera; I Weets; E Vandemeulebroucke; I H de Leeuw; B Keymeulen; C Mathieu; R Rottiers; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

9.  Newborn HLA-DR,DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk estimates.

Authors:  Lisa M Emery; Sunanda Babu; Teodorica L Bugawan; Jill M Norris; Henry A Erlich; George S Eisenbarth; Marian Rewers
Journal:  Pediatr Diabetes       Date:  2005-09       Impact factor: 4.866

10.  Familial type 1 diabetes mellitus - gender distribution and age at onset of diabetes distinguish between parent-offspring and sib-pair subgroups.

Authors:  Yael Lebenthal; Liat de Vries; Moshe Phillip; Liora Lazar
Journal:  Pediatr Diabetes       Date:  2009-12-02       Impact factor: 4.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.